VITRA PHARMACEUTICALS LIMITED
Patent Applications and Registrations
Patent applications and USPTO patent grants for VITRA PHARMACEUTICALS LIMITED.The latest application filed is for "mono (iron hydroxypyrone) and combination (iron hydroxypyrone and gi inflammation inhibiting agents) compositions for anaemia or h. pylori infections".
- VITRA PHARMACEUTICALS LIMITED - Essex GB
- Vitra Pharmaceuticals Limited - Saffron Walden Essex GB
- Vitra Pharmaceuticals, Ltd. - Saffron Walden Essex GB
- Vitra Pharmaceuticals Ltd. - GB GB
| Patent | Date |
|---|---|
| Mono (iron Hydroxypyrone) And Combination (iron Hydroxypyrone And Gi Inflammation Inhibiting Agents) Compositions For Anaemia Or H. Pylori Infections App 20110177172 - Stockham; Michael Arthur | 2011-07-21 |
| Method of forming iron hydroxypyrone compounds Grant 7,459,569 - Stockham December 2, 2 | 2008-12-02 |
| Iron compositions Grant 7,135,196 - Stockham November 14, 2 | 2006-11-14 |
| Iron compounds, compositions, methods of making the same and uses thereof Grant 6,635,631 - Stockham , et al. October 21, 2 | 2003-10-21 |
| Iron compounds, compositions, methods of making the same and uses thereof Grant 6,339,080 - Stockham , et al. January 15, 2 | 2002-01-15 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 